MedPath

长春生物制品研究所有限责任公司

Ownership
-
Established
1985-12-05
Employees
-
Market Cap
-
Website
https://www.ccbio.net

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

74

NMPA:74

Drug Approvals

Rabies Vaccine (Vero cell) for Human Use,Freeze-dried

Product Name
冻干人用狂犬病疫苗(Vero细胞)
Approval Number
国药准字S20210014
Approval Date
Apr 30, 2021
NMPA

Recombinant Human Interferon α2a for Injection

Product Name
注射用重组人干扰素α2a
Approval Number
国药准字S20010031
Approval Date
Aug 31, 2020
NMPA

Recombinant Human Interferon α2a for Injection

Product Name
注射用重组人干扰素α2a
Approval Number
国药准字S10960043
Approval Date
Aug 31, 2020
NMPA

Recombinant Human Interferon α2a for Injection

Product Name
注射用重组人干扰素α2a
Approval Number
国药准字S10960044
Approval Date
Aug 31, 2020
NMPA

Recombinant Human Interferon α2b for Injection

Product Name
长生扶康
Approval Number
国药准字S20010044
Approval Date
Aug 31, 2020
NMPA

Recombinant Human Interferon α2b for Injection

Product Name
长生扶康
Approval Number
国药准字S20010043
Approval Date
Aug 31, 2020
NMPA

Recombinant Human Interleukin-2 for Injection

Product Name
注射用重组人白介素-2
Approval Number
国药准字S20063103
Approval Date
Aug 31, 2020
NMPA

Recombinant Human Interleukin-2 for Injection

Product Name
注射用重组人白介素-2
Approval Number
国药准字S20063101
Approval Date
Aug 31, 2020
NMPA

Recombinant Human Interleukin-2 for Injection

Product Name
注射用重组人白介素-2
Approval Number
国药准字S20063102
Approval Date
Aug 31, 2020
NMPA

Human Interferon α1b Eye Drops

Product Name
长生扶明
Approval Number
国药准字S10960042
Approval Date
Aug 31, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath